{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:39:10Z","timestamp":1792370350555,"version":"4.4.0"},"reference-count":48,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2021.10781","type":"journal-article","created":{"date-parts":[[2021,9,22]],"date-time":"2021-09-22T08:23:01Z","timestamp":1632298981000},"source":"Crossref","is-referenced-by-count":21,"title":["A systematic review of euthyroid Graves' disease (Review)"],"prefix":"10.3892","volume":"22","author":[{"given":"Mioara-Laura","family":"Macovei","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0170nal","family":"Azis","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Gheorghe","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Burcea","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, \u2018Carol Davila\u2019 University of Medicine and Pharmacy, 050474 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2021,9,22]]},"reference":[{"key":"key20211014132819_b1-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1167\/iovs.14-14002","article-title":"Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy","volume":"55","author":"Wang","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"201","key":"key20211014132819_b2-ETM-0-0-10781","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-020-01459-7","article-title":"Prevalence of hyperthyroidism, hypothyroidism, and euthyroidism in thyroid eye disease: A systematic review of the literature","volume":"9","author":"Mu\u00f1oz-Ortiz","year":"2020","journal-title":"Syst Rev"},{"key":"key20211014132819_b3-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1038\/eye.2012.132","article-title":"Clinical features of thyroid-associated ophthalmopathy in clinically euthyroid Korean patients","volume":"26","author":"Jang","year":"2012","journal-title":"Eye (Lond)"},{"issue":"184","key":"key20211014132819_b4-ETM-0-0-10781","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00184","article-title":"Not all orbitopathy is Graves': Discussion of cases and review of literature","volume":"8","author":"Boddu","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"426898","key":"key20211014132819_b5-ETM-0-0-10781","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/426898","article-title":"The influence of prior hyperthyroidism on euthyroid graves' ophthalmopathy","volume":"2014","author":"Termote","year":"2014","journal-title":"J Ophthalmol"},{"key":"key20211014132819_b6-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1016\/0002-9343(86)90686-8","article-title":"Euthyroid Graves' disease. Report of a case observed over a 12-year period","volume":"80","author":"Peter","year":"1986","journal-title":"Am J Med"},{"key":"key20211014132819_b7-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"392.e1","DOI":"10.1016\/j.ophtha.2006.10.012","article-title":"Graves' orbitopathy","volume":"114","author":"Bhatnagar","year":"2007","journal-title":"Ophthalmology"},{"key":"key20211014132819_b8-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.2147\/OPTH.S61041","article-title":"The relationship between sex and symmetry in thyroid eye disease","volume":"8","author":"Kavoussi","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"key20211014132819_b9-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"725","DOI":"10.20452\/pamw.3592","article-title":"Cigarette smoking: Number one enemy for Graves ophthalmopathy","volume":"126","author":"Bartalena","year":"2016","journal-title":"Pol Arch Med Wewn"},{"key":"key20211014132819_b10-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/BF03348001","article-title":"Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects","volume":"20","author":"Takasu","year":"1997","journal-title":"J Endocrinol Invest"},{"key":"key20211014132819_b11-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1046\/j.1365-2265.2000.00959.x","article-title":"Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy","volume":"52","author":"Gerding","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key20211014132819_b12-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1365-2265.1991.tb01736.x","article-title":"Genetic differences shown by HLA typing among Japanese patients with euthyroid Graves' ophthalmopathy, Graves' disease and Hashimoto's thyroiditis: Genetic characteristics of euthyroid Graves' ophthalmopathy","volume":"34","author":"Inoue","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"key20211014132819_b13-ETM-0-0-10781","doi-asserted-by":"publisher","DOI":"10.1186\/1756-6614-5-4","article-title":"Eye findings and immunological markers in probands and their euthyroid relatives from a single family with multiple cases of thyroid autoimmunity","volume":"5","author":"Ardley","year":"2012","journal-title":"Thyroid Res"},{"key":"key20211014132819_b14-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1089\/thy.2007.0185","article-title":"Pathogenesis of Graves' ophthalmopathy: The role of autoantibodies","volume":"17","author":"Khoo","year":"2007","journal-title":"Thyroid"},{"key":"key20211014132819_b15-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.mcna.2012.01.014","article-title":"The evaluation and treatment of Graves ophthalmopathy","volume":"96","author":"Stan","year":"2012","journal-title":"Med Clin North Am"},{"key":"key20211014132819_b16-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1046\/j.1365-2265.2003.01708.x","article-title":"TSH-R expression and cytokine profile in orbital tissue of active vs inactive Graves' ophthalmopathy patients","volume":"58","author":"Wakelkamp","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key20211014132819_b17-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1365-2249.2006.03110.x","article-title":"Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease","volume":"145","author":"Gopinath","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"key20211014132819_b18-ETM-0-0-10781","first-page":"2534","article-title":"Case report a case of unilateral euthyroid Graves' disease","volume":"3","author":"Krishnan","year":"2015","journal-title":"Sch J App Med Sci"},{"key":"key20211014132819_b19-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1097\/IOP.0000000000001052","article-title":"Thyrotropin receptor antibodies-an overview","volume":"34 (Suppl 1)","author":"Kotwal","year":"2018","journal-title":"Ophthal Plast Reconstr Surg"},{"key":"key20211014132819_b20-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/s0002-9394(14)72787-4","article-title":"Diagnostic criteria for Graves' ophthalmopathy","volume":"119","author":"Bartley","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"key20211014132819_b21-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1001\/archophthalmol.2011.29","article-title":"Rundle and His Curve","volume":"129","author":"Bartley","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"key20211014132819_b22-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1089\/thy.2000.10.799","article-title":"Increased frequency of euthyroid ophthalmopathy in patients with Graves' disease associated with myasthenia gravis","volume":"10","author":"Marin\u00f2","year":"2000","journal-title":"Thyroid"},{"issue":"5250","key":"key20211014132819_b23-ETM-0-0-10781","article-title":"Clinical feature of euthyroid Graves' ophthalmopathy","volume":"49","author":"Komoto","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"key20211014132819_b24-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1136\/bjo.2007.137265","article-title":"Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy","volume":"93","author":"Eckstein","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"key20211014132819_b25-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/BF03350193","article-title":"Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease","volume":"11","author":"Wiersinga","year":"1988","journal-title":"J Endocrinol Invest"},{"key":"key20211014132819_b26-ETM-0-0-10781","first-page":"1547","article-title":"Euthyroid Graves' ophthalmopathy with negative autoantibodies","volume":"97","author":"Cakir","year":"2005","journal-title":"J Natl Med Assoc"},{"key":"key20211014132819_b27-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.beem.2011.09.005","article-title":"Treating the thyroid in the presence of Graves' ophthalmopathy","volume":"26","author":"Heged\u00fcs","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key20211014132819_b28-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1089\/thy.2000.10.1093","article-title":"Graves' ophthalmopathy in the absence of elevated free thyroxine and triiodothyronine levels: Prevalence, natural history, and thyrotropin receptor antibody levels","volume":"10","author":"Khoo","year":"2000","journal-title":"Thyroid"},{"key":"key20211014132819_b29-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1365-2796.1995.tb01214.x","article-title":"Euthyroid Graves' disease showing no thyroid abnormalities except positive thyroid-sstimulating antibody (TSAb): Two case reports","volume":"238","author":"Watanabe","year":"1995","journal-title":"J Intern Med"},{"key":"key20211014132819_b30-ETM-0-0-10781","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/TEN.0b013e3181a69886","article-title":"A case of euthyroid Graves disease which developed into Graves disease with thyrotoxicosis after subacute thyroiditis","volume":"19","author":"Tanaka","year":"2009","journal-title":"The Endocrinologist"},{"key":"key20211014132819_b31-ETM-0-0-10781","article-title":"Euthyroid Graves' ophthalmopathy patients remaining stable on more than 20 months follow up-a report of 9 patients","author":"Majumder","year":"2019","journal-title":"Hot Thyroidol"},{"issue":"1707959","key":"key20211014132819_b32-ETM-0-0-10781","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/1707959","article-title":"A case of euthyroid Graves' ophthalmopathy in a patient sero-negative for TSH receptor autoantibody","volume":"2018","author":"Hotta","year":"2018","journal-title":"Case Rep Endocrinol"},{"issue":"160008","key":"key20211014132819_b33-ETM-0-0-10781","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-16-0008","article-title":"Thyroid antibody-negative euthyroid Graves' ophthalmopathy","volume":"2016","author":"Tabasum","year":"2016","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"key20211014132819_b34-ETM-0-0-10781","first-page":"S60","article-title":"Thyroid ophthalmopathy","volume":"59 (Suppl 1)","author":"Shah","year":"2011","journal-title":"J Assoc Physicians India"},{"key":"key20211014132819_b35-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.2169\/internalmedicine.48.2372","article-title":"Unilateral optic neuropathy as the initial manifestation of euthyroid Graves' disease","volume":"48","author":"Arslan","year":"2009","journal-title":"Intern Med"},{"key":"key20211014132819_b36-ETM-0-0-10781","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/01658107.2012.688237","article-title":"Intravenous pulse corticosteroid therapy in euthyroid optic neuropathy: A case report","volume":"36","author":"Lee","year":"2012","journal-title":"Neuro Ophthalmol"},{"key":"key20211014132819_b37-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"e188","DOI":"10.1016\/j.jcjo.2018.10.014","article-title":"Spontaneous resolution of euthyroid optic neuropathy","volume":"54","author":"Kitaguchi","year":"2019","journal-title":"Can J Ophthalmol"},{"key":"key20211014132819_b38-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1046\/j.1365-2265.2001.01349.x","article-title":"Controversies in the clinical evaluation of active thyroid-associated orbitopathy: Use of a detailed protocol with comparative photographs for objective assessment","volume":"55","author":"Dickinson","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2106","key":"key20211014132819_b39-ETM-0-0-10781","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.04.034","article-title":"Thyroid-associated inferior oblique myopathy","volume":"114","author":"Kakizaki","year":"2007","journal-title":"Ophthalmology"},{"key":"key20211014132819_b40-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1159\/000443828","article-title":"The 2016 European thyroid association\/European group on Graves' orbitopathy guidelines for the management of Graves' orbitopathy","volume":"5","author":"Bartalena","year":"2016","journal-title":"Eur Thyroid J"},{"key":"key20211014132819_b41-ETM-0-0-10781","first-page":"529","article-title":"Euthyroid ophthalmopathy: A rare case report and a brief review of literature","volume":"4","author":"Wawhal","year":"2015","journal-title":"Int J Sci Res"},{"key":"key20211014132819_b42-ETM-0-0-10781","doi-asserted-by":"crossref","first-page":"227","DOI":"10.4183\/aeb.2005.227","article-title":"Late onset Graves' thyrotoxicosis in a patient with 18 years history of euthyroid Graves' ophthalmopathy","volume":"1","author":"Ursu","year":"2005","journal-title":"Acta Endo (Buc)"},{"key":"key20211014132819_b43-ETM-0-0-10781","first-page":"7150","article-title":"Graves ophthalmopathy in a euthyroid patient-a rare case report","volume":"3","author":"Sarkar","year":"2014","journal-title":"J Evol Med Dent Sci"},{"key":"key20211014132819_b44-ETM-0-0-10781","doi-asserted-by":"crossref","first-page":"1","DOI":"10.31871\/WJRR.9.6.6","article-title":"A case of unilateral exophthalmos due to thyroid orbitopathy in a clinically euthyroid patient","volume":"9","author":"Khan","year":"2019","journal-title":"World J Res Rev"},{"key":"key20211014132819_b45-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"739","DOI":"10.2147\/OPTH.S158967","article-title":"Clinical course of thyroid function and thyroid associated-ophthalmopathy in patients with euthyroid Graves' disease","volume":"12","author":"Suzuki","year":"2018","journal-title":"Clin Ophthalmol"},{"key":"key20211014132819_b46-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N Engl J Med"},{"key":"key20211014132819_b47-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1210\/jc.2014-2572","article-title":"Randomized controlled trial of rituximab in patients with Graves' orbitopathy","volume":"100","author":"Stan","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"key20211014132819_b48-ETM-0-0-10781","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40123-019-00226-9","article-title":"Current understanding of the progression and management of thyroid associated orbitopathy: A systematic review","volume":"9","author":"Hodgson","year":"2020","journal-title":"Ophthalmol Ther"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2021,10,14]],"date-time":"2021-10-14T16:15:44Z","timestamp":1634228144000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2021.10781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,22]]},"references-count":48,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2021,9,22]]}},"URL":"https:\/\/doi.org\/10.3892\/etm.2021.10781","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,22]]},"article-number":"1346"}}